Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
about
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyEpendymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.Overcoming multiple drug resistance mechanisms in medulloblastoma.Pediatric diffuse intrinsic pontine glioma patients from a single center.
P2860
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@en
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@nl
type
label
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@en
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@nl
prefLabel
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@en
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@nl
P2093
P2860
P1476
Temozolomide in relapsed pediatric brain tumors: 14 cases from a single center.
@en
P2093
Bilgehan Yalçin
Canan Akyüz
Haci Ahmet Demir
Münevver Büyükpamukçu
Tezer Kutluk
P2860
P2888
P304
P356
10.1007/S00381-011-1561-3
P577
2011-08-25T00:00:00Z